INTERNATIONAL PATENT: VESIGEN, INC. FILES APPLICATION FOR "ARRDC1-MEDIATED MICROVESICLE-BASED DELIVERY OF THERAPEUTIC AGENTS TO CELLS AND TISSUES OF THE EYE"

GENEVA, Sept. 10 -- VESIGEN, INC. (1188 Centre Street, 1st FloorNewton, Massachusetts 02459) filed a patent application (PCT/US2025/017855) for "ARRDC1-MEDIATED MICROVESICLE-BASED DELIVERY OF THERAPEUTIC AGENTS TO CELLS AND TISSUES OF THE EYE" on Feb 28, 2025. With publication no. WO/2025/184515, the details related to the patent application was published on Sep 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHINCHORE, Yashodhan (1188 Centre Street, 1st FloorNewton, Massachusetts 02459)

Abstract: Provided herein are methods, systems, and compositions for ARMMs-mediated treatment of A...